Epidermal growth factor receptors (EGFRs) have been suggested as prognostic markers and potential therapeutic targets in several neoplasms in both human and veterinary medicine, among these is human cutaneous melanoma. This evidence concerns the gene EGFR and cutaneous melanoma.